Idera Pharmaceuticals Inc (IDRA)

[Anakiin]

Yes part of the pullback was due to the BIO sector weakness. That is For Sure. My point is that going back up to 6-7$ area on stellar results would be disappointing. I was hoping to see 9-10$ at least and move from there. I have high expectation for this stock 2 years term...this drop is very bad as phase II results are usually key to get a nice spike up in a bio stock